Notably, EGFR- and KRAS-mutant NSCLC cases typically exhibit a reduced proportion of TILs and corresponding low ICR expression, indicating a deficiency in immune engagement rather than a fully functional T cell population [76]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.